No differences were observed in the rate of viral hepatitis screening in the cohort of 26 individuals with current or previous therapy with corticoids (anti-HCV: p = 0.543, HBsAg: p = 0.543, anti-HBc: p = 0.227, complete viral hepatitis testing: p = 0.192). This evidence concerns the gene KRT88P and viral hepatitis.